February 27, 2020 / 1:15 PM / a month ago

BRIEF-Esperion Q4 Loss Per Share $2.26

Feb 27 (Reuters) - Esperion Therapeutics Inc:

* ESPERION PROVIDES LIPID MANAGEMENT FRANCHISE UPDATES; REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $2.26

* Q4 REVENUE $1.0 MILLION VERSUS REFINITIV IBES ESTIMATE OF $892,000

* Q4 EARNINGS PER SHARE ESTIMATE $-2.67 — REFINITIV IBES DATA

* EXPECTS RESOURCES, MILESTONE PAYMENTS ARE SUFFICIENT TO FUND OPERATIONS THROUGH PROFITABILITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below